找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

12345
返回列表
打印 上一主題 下一主題

Titlebook: Disease-modifying Therapy in Vasculitides; Cees G. M. Kallenberg,Jan W. Cohen Tervaert Book 2001 Birkh?user Verlag 2001 Internal medicine.

[復(fù)制鏈接]
樓主: hexagon
41#
發(fā)表于 2025-3-28 16:53:36 | 只看該作者
42#
發(fā)表于 2025-3-28 20:46:03 | 只看該作者
T-cell directed treatment: anti-thymocyte globulin, with a cumulative dose higher than 100 g [.]. There is a definite need to replace cyclophosphamide in these refractory cases. In other patients, standard treatment has to be avoided because severe side-effects already developed. Few patients have been reported to have responded to Cyclosporin A [.]
43#
發(fā)表于 2025-3-29 02:19:55 | 只看該作者
44#
發(fā)表于 2025-3-29 06:22:08 | 只看該作者
45#
發(fā)表于 2025-3-29 09:39:29 | 只看該作者
Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-verapy after a remission is induced with cyclophosphamide and steroids [.]. Azathioprine is considered less effective in inducing remission than cyclophosphamide, but its long-term toxicity is much lower [., .]. The potential of azathioprine as maintenance therapy was recently investigated and compar
46#
發(fā)表于 2025-3-29 12:29:18 | 只看該作者
10樓
47#
發(fā)表于 2025-3-29 18:14:30 | 只看該作者
10樓
48#
發(fā)表于 2025-3-29 20:00:35 | 只看該作者
10樓
12345
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 03:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洮南市| 尤溪县| 伊吾县| 临桂县| 新巴尔虎右旗| 汾西县| 金平| 北辰区| 罗城| 美姑县| 天全县| 玉屏| 衢州市| 泸州市| 曲阳县| 福建省| 剑河县| 藁城市| 五家渠市| 常州市| 海宁市| 平潭县| 大港区| 东明县| 成都市| 金川县| 兴文县| 咸丰县| 西平县| 永康市| 洛南县| 新化县| 称多县| 历史| 团风县| 海盐县| 陆川县| 青岛市| 曲沃县| 云浮市| 鄂托克前旗|